| __timestamp | Supernus Pharmaceuticals, Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72471000 | 7461000 |
| Thursday, January 1, 2015 | 89204000 | 11960000 |
| Friday, January 1, 2016 | 106010000 | 13108000 |
| Sunday, January 1, 2017 | 137905000 | 17501000 |
| Monday, January 1, 2018 | 159888000 | 22472000 |
| Tuesday, January 1, 2019 | 158425000 | 24286000 |
| Wednesday, January 1, 2020 | 200677000 | 29689000 |
| Friday, January 1, 2021 | 304759000 | 38837000 |
| Saturday, January 1, 2022 | 377221000 | 47489000 |
| Sunday, January 1, 2023 | 336361000 | 53379000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, operational efficiency is key. Over the past decade, Supernus Pharmaceuticals, Inc. and Xencor, Inc. have demonstrated contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. Supernus Pharmaceuticals has seen a staggering 365% increase in SG&A costs from 2014 to 2023, peaking in 2022. This growth reflects their aggressive expansion and market penetration strategies. In contrast, Xencor, Inc. has maintained a more conservative approach, with a 615% increase over the same period, yet their expenses remain significantly lower than Supernus. This divergence highlights differing business models: Supernus's high expenditure aligns with a robust market presence, while Xencor's leaner operations suggest a focus on innovation and strategic partnerships. As the industry continues to evolve, these trends offer valuable insights into the operational strategies of these two pharmaceutical giants.
Dr. Reddy's Laboratories Limited or Supernus Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Sarepta Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Corcept Therapeutics Incorporated or Xencor, Inc.: Who Manages SG&A Costs Better?
Alkermes plc vs Supernus Pharmaceuticals, Inc.: SG&A Expense Trends
Opthea Limited and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Alpine Immune Sciences, Inc. vs Supernus Pharmaceuticals, Inc.
ADMA Biologics, Inc. or Xencor, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Rhythm Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Supernus Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Cost of Revenue: Key Insights for Supernus Pharmaceuticals, Inc. and Xencor, Inc.
Cost Management Insights: SG&A Expenses for Travere Therapeutics, Inc. and Xencor, Inc.